Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) EPS (Weighted Average and Diluted) (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.11 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 99.94% to -$0.11 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.6 through Dec 2025, up 71.56% year-over-year, with the annual reading at -$0.6 for FY2025, 71.56% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.11 at Nuvation Bio, up from -$0.16 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.07 in Q4 2023, with the low at -$183.97 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$15.59, with a median of -$0.13 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 262709.05% in 2024, then soared 99.94% in 2025.
  • Over 3 years, EPS (Weighted Average and Diluted) stood at -$0.07 in 2023, then crashed by 262709.05% to -$183.97 in 2024, then skyrocketed by 99.94% to -$0.11 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.11, -$0.16, and -$0.17 for Q4 2025, Q3 2025, and Q2 2025 respectively.